I2Pure
I2Pure specializes in molecular iodine-based technologies for broad-spectrum infection prevention and biosafety across healthcare, consumer, and industrial markets. Its mission is to prevent pathogenic threats globally by developing, optimizing, and licensing stable, non-toxic molecular iodine solutions. The company focuses on formulation, clinical validation, manufacturing, and regulatory compliance related to antiseptic and antimicrobial products, supported by ongoing research into iodine chemistry, bioavailability, and delivery at biological interfaces.
Industries
N/A
I2Pure
44679 Endicott Drive, Suite 300, Ashburn, VA 20147
Patents
High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses
2025-12-02 • US-12485141-B2
View Details
High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses
2025-12-02 • US-12485141-B2
View DetailsProducts
Dual-action gel providing molecular iodine-based broad-spectrum antimicrobial action with glycerin for skin hydration and barrier protection. Used for treatment and prevention of infection in minor wounds, burns, and irritations.
Pre-moistened swabs with high-concentration molecular iodine for pre-procedure microbial decolonization of the nasal passages.
Hand sanitizing solution containing molecular iodine and alcohol for rapid, broad-spectrum antimicrobial action.
Topical serum targeting active breakouts with alcohol-free, molecular iodine-based formulation for sensitive or irritated skin.
Serum with molecular iodine for whole-body use, supporting recovery from irritation and breakouts while providing time-released protection.
Dual-action gel providing molecular iodine-based broad-spectrum antimicrobial action with glycerin for skin hydration and barrier protection. Used for treatment and prevention of infection in minor wounds, burns, and irritations.
Pre-moistened swabs with high-concentration molecular iodine for pre-procedure microbial decolonization of the nasal passages.
Hand sanitizing solution containing molecular iodine and alcohol for rapid, broad-spectrum antimicrobial action.
Topical serum targeting active breakouts with alcohol-free, molecular iodine-based formulation for sensitive or irritated skin.
Serum with molecular iodine for whole-body use, supporting recovery from irritation and breakouts while providing time-released protection.
Services
Provision of worldwide patent licenses for use of molecular iodine technology in water disinfection, healthcare, and consumer products, including support for integration and regulatory documentation.
Contract manufacturing for molecular iodine products, including custom formulations, quality assurance, and fulfillment for third parties.
Provision of worldwide patent licenses for use of molecular iodine technology in water disinfection, healthcare, and consumer products, including support for integration and regulatory documentation.
Contract manufacturing for molecular iodine products, including custom formulations, quality assurance, and fulfillment for third parties.
Expertise Areas
- Antimicrobial formulation development
- Clinical validation of novel therapeutics
- Medical device coatings
- Biofilm eradication
Key Technologies
- Molecular iodine stabilization
- Antimicrobial coatings
- Polymer-iodine integration
- Broad-spectrum biocidal formulations
Key People
Director, Quality Engineering
Orthopedics Advisor
Director, Quality Engineering
Orthopedics Advisor
News & Updates
Recognized for innovative impact on technology solutions in biosafety and healthcare.
Awarded in an international open innovation competition for advancements in iodine-based solutions.
Recognition of Chief Scientist Dr. Ilker Bayer within the top 0.05% of global scholars for scientific productivity and impact.
Study demonstrating safety and biofilm eradication by molecular iodine at high concentrations on human skin explants.
Peer-reviewed research disproving the traditional view associating molecular iodine with skin toxicity and staining.
Research article describing the mechanisms and modeling of molecular iodine release from iodophor formulations across hydrophilic–lipophilic interfaces, with implications for drug delivery and antimicrobial efficacy.
Recognized for innovative impact on technology solutions in biosafety and healthcare.
Awarded in an international open innovation competition for advancements in iodine-based solutions.
Recognition of Chief Scientist Dr. Ilker Bayer within the top 0.05% of global scholars for scientific productivity and impact.
Study demonstrating safety and biofilm eradication by molecular iodine at high concentrations on human skin explants.
Peer-reviewed research disproving the traditional view associating molecular iodine with skin toxicity and staining.
Research article describing the mechanisms and modeling of molecular iodine release from iodophor formulations across hydrophilic–lipophilic interfaces, with implications for drug delivery and antimicrobial efficacy.